116 related articles for article (PubMed ID: 17227205)
1. Cysteine at position 217 in the intracellular loop 1 plays a critical role in human PTH receptor type 1 membrane translocation and function.
Thomas BE; Wittelsberger A; Woznica I; Hsieh MY; Monaghan P; Lee BK; Rosenblatt M
J Bone Miner Res; 2007 Apr; 22(4):609-16. PubMed ID: 17227205
[TBL] [Abstract][Full Text] [Related]
2. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of a type 1 parathyroid hormone receptor intracellular tail mutant [KRK(484-6)AAA]: effects on second messenger generation and cellular targeting.
Patterson EK; Hodsman AB; Hendy GN; Canaff L; Bringhurst FR; Fraher LJ
Bone; 2010 Apr; 46(4):1180-7. PubMed ID: 20006743
[TBL] [Abstract][Full Text] [Related]
4. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
[TBL] [Abstract][Full Text] [Related]
5. Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2.
Fei YJ; Liu W; Prasad PD; Kekuda R; Oblak TG; Ganapathy V; Leibach FH
Biochemistry; 1997 Jan; 36(2):452-60. PubMed ID: 9003198
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.
Sucic S; Bryan-Lluka LJ
Eur J Pharmacol; 2007 Feb; 556(1-3):27-35. PubMed ID: 17141753
[TBL] [Abstract][Full Text] [Related]
7. Functional type I PTH/PTHrP receptor in freshly isolated newborn rat keratinocytes: identification by RT-PCR and immunohistochemistry.
Errazahi A; Bouizar Z; Lieberherr M; Souil E; Rizk-Rabin M
J Bone Miner Res; 2003 Apr; 18(4):737-50. PubMed ID: 12674335
[TBL] [Abstract][Full Text] [Related]
8. Ligand binding and signalling pathways of PTH receptors in sea bream (Sparus auratus) enterocytes.
Rotllant J; Guerreiro PM; Redruello B; Fernandes H; Apolónia L; Anjos L; Canario AV; Power DM
Cell Tissue Res; 2006 Feb; 323(2):333-41. PubMed ID: 16189716
[TBL] [Abstract][Full Text] [Related]
9. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor.
Timossi C; Ortiz-Elizondo C; Pineda DB; Dias JA; Conn PM; Ulloa-Aguirre A
Mol Cell Endocrinol; 2004 Aug; 223(1-2):17-26. PubMed ID: 15279907
[TBL] [Abstract][Full Text] [Related]
10. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
[TBL] [Abstract][Full Text] [Related]
11. Conformational changes in the parathyroid hormone receptor associated with activation by agonist.
Thomas BE; Woznica I; Mierke DF; Wittelsberger A; Rosenblatt M
Mol Endocrinol; 2008 May; 22(5):1154-62. PubMed ID: 18258686
[TBL] [Abstract][Full Text] [Related]
12. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
del Camino D; Barros F; Pardo LA; de la Peña P
Biochemistry; 1997 Mar; 36(11):3308-18. PubMed ID: 9116009
[TBL] [Abstract][Full Text] [Related]
13. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
[TBL] [Abstract][Full Text] [Related]
14. The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues.
Schülein R; Zühlke K; Oksche A; Hermosilla R; Furkert J; Rosenthal W
FEBS Lett; 2000 Jan; 466(1):101-6. PubMed ID: 10648821
[TBL] [Abstract][Full Text] [Related]
15. The mid-region of parathyroid hormone (1-34) serves as a functional docking domain in receptor activation.
Wittelsberger A; Corich M; Thomas BE; Lee BK; Barazza A; Czodrowski P; Mierke DF; Chorev M; Rosenblatt M
Biochemistry; 2006 Feb; 45(7):2027-34. PubMed ID: 16475791
[TBL] [Abstract][Full Text] [Related]
16. Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers.
Dosch DD; Ballmer-Hofer K
FASEB J; 2010 Jan; 24(1):32-8. PubMed ID: 19726758
[TBL] [Abstract][Full Text] [Related]
17. Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists.
Tran DT; Bonaventure P; Hack M; Mirzadegan T; Dvorak C; Letavic M; Carruthers N; Lovenberg T; Sutton SW
Eur J Pharmacol; 2011 Sep; 667(1-3):120-8. PubMed ID: 21679703
[TBL] [Abstract][Full Text] [Related]
18. Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding.
Lee C; Gardella TJ; Abou-Samra AB; Nussbaum SR; Segre GV; Potts JT; Kronenberg HM; Jüppner H
Endocrinology; 1994 Oct; 135(4):1488-95. PubMed ID: 7523099
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d.
Markovic D; Lehnert H; Levine MA; Grammatopoulos DK
Mol Endocrinol; 2008 Nov; 22(11):2505-19. PubMed ID: 18772229
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.
Dean T; Linglart A; Mahon MJ; Bastepe M; Jüppner H; Potts JT; Gardella TJ
Mol Endocrinol; 2006 Apr; 20(4):931-43. PubMed ID: 16339275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
